Is the business good?
How good a business is CC?
The Chemours Company earns −2.8% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
−2.8%
Return on invested capital · cost of capital 9.0% · 12 points below what the capital costs: growth destroys value
- Operating margin
- −1.9%
Operating margin · Specialty Chemicals median 9.1% · 12 months to Q2 2026
- Share count, year on year
- +0.66%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 1.8%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | 7.4% |
| FY2021 | 11% |
| FY2022 | 11% |
| FY2023 | −4.0% |
| FY2024 | 5.5% |
| FY2025 | −1.1% |
Details›
- Gross margin12 months to Q2 2026
- 15%
- Operating margin12 months to Q2 2026
- −1.9%
- Net margin12 months to Q2 2026
- −5.2%
- Free cash flow margin
- 3.8%
- R&D as % of revenue
- 1.8%
- Revenue, trailing twelve months
- $5.80B
- Free cash flow, trailing twelve months
- $218M
- Net income, trailing twelve months
- −$304M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −2.8%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Specialty Chemicals
Ranks #26 of 36 by Smart Score